The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
A modified oestrogen receptor ligand-binding domain as an improved switch for the regulation of heterologous proteins
Open accessAbstract
A number of proteins have been rendered functionally oestrogen-dependent by fusion with the hormone-binding domain of the oestrogen receptor. There are, however, several significant disadvantages with such fusion proteins. First, their use in cells in vitro requires phenol red-free medium and laborious stripping of steroid hormones from serum in order to avoid constitutive activation. Secondly, control of oestrogen receptor fusion proteins in vivo is precluded by high endogenous levels of circulating oestrogens. Thirdly, the hormone-binding domain of the oestrogen receptor functions as a hormone-dependent transcriptional activation domain making interpretation of fusions with transcription factors problematical. In order to overcome these drawbacks we have used a transcriptionally inactive mutant of the murine oestrogen receptor which is unable to bind oestrogen yet retains normal affinity for the synthetic ligand, 4-hydroxytamoxifen. When the hormone-binding domain of this mutant oestrogen receptor is fused to the C-terminus of the c-Myc protein, Myc-induced proliferation and apoptosis in fibroblasts becomes dependent on 4-hydroxytamoxifen, but remains refractory to 17 beta-oestradiol.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Induction of apoptosis in fibroblasts by c-myc protein
Evan, G. I., Wyllie, A. H., Gilbert, C. S., Littlewood, T. D., Land, H., Brooks, M., Waters, C. M., Penn, L. Z., & Hancock, D. C. (1992) · Cell · doi:10.1016/0092-8674(92)90123-t · Cited by 2,935
Self-citationMorgenstern, J. P., & Land, H. (1990) · Nucleic Acids Research · doi:10.1093/nar/18.12.3587 · Cited by 2,101
Berthois, Y., Katzenellenbogen, J. A., & Katzenellenbogen, B. S. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.8.2496 · Cited by 1,307
The human estrogen receptor has two independent nonacidic transcriptional activation functions
Tora, L., White, J., Brou, C., Tasset, D., Webster, N., Scheer, E., & Chambon, P. (1989) · Cell · doi:10.1016/0092-8674(89)90031-7 · Cited by 1,048
Isolation of Monoclonal Antibodies Specific for Human c-myc Proto-Oncogene Product
Evan, G. I., Lewis, G. K., Ramsay, G., & Bishop, J. M. (1985) · Molecular and Cellular Biology · doi:10.1128/mcb.5.12.3610-3616.1985 · Cited by 794
Self-citationBerry, M., Metzger, D., & Chambon, P. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb07469.x · Cited by 767
Cooperative interaction between c-myc and bcl-2 proto-oncogenes
Fanidi, A., Harrington, E. A., & Evan, G. I. (1992) · Nature · doi:10.1038/359554a0 · Cited by 759
Self-citationc-Myc-induced apoptosis in fibroblasts is inhibited by specific cytokines.
Harrington, E. A., Bennett, M. R., Fanidi, A., & Evan, G. I. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06630.x · Cited by 742
Self-citationCCAAT-Enhancer Binding Protein: A Component of a Differentiation Switch
Umek, R. M., Friedman, A. D., & McKnight, S. L. (1991) · Science · doi:10.1126/science.1987644 · Cited by 712
WEBSTER, N. (1988) · Cell · doi:10.1016/0092-8674(88)90552-1 · Cited by 580
The MYC protein activates transcription of the alpha-prothymosin gene.
Eilers, M., Schirm, S., & Bishop, J. M. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb07929.x · Cited by 578
Steroid receptors and their associated proteins
Smith, D. F. (1993) · Molecular Endocrinology · doi:10.1210/me.7.1.4 · Cited by 545
Kumar, V., Green, S., Staub, A., & Chambon, P. (1986) · The EMBO Journal · doi:10.1002/j.1460-2075.1986.tb04489.x · Cited by 530
Chimaeras of Myc oncoprotein and steroid receptors cause hormone-dependent transformation of cells
Eilers, M., Picard, D., Yamamoto, K. R., & Bishop, J. M. (1989) · Nature · doi:10.1038/340066a0 · Cited by 458
Contrasting actions of tamoxifen on endometrial and breast tumor growth in the athymic mouse.
Gottardis, M. M., Robinson, S. P., SATYASWAROOP, P. G., & Jordan, V. C. (1988) · PubMed · Cited by 422
The cloned human oestrogen receptor contains a mutation which alters its hormone binding properties.
Tora, L., Mullick, A., Metzger, D., Ponglikitmongkol, M., Park, I., & Chambon, P. (1989) · The EMBO Journal · doi:10.1002/j.1460-2075.1989.tb03604.x · Cited by 417
Biochemical pharmacology of antiestrogen action.
Jordan, V. C. (1984) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06650-5 · Cited by 417
Picard, D., Salser, S. J., & Yamamoto, K. R. (1988) · Cell · doi:10.1016/0092-8674(88)90122-5 · Cited by 410
Endocrine Pharmacology of Antiestrogens as Antitumor Agents*
JORDAN, V. C., & MURPHY, C. S. (1990) · Endocrine Reviews · doi:10.1210/edrv-11-4-578 · Cited by 400
The c-Myc protein induces cell cycle progression and apoptosis through dimerization with Max.
Amati, B., Littlewood, T. D., Evan, G. I., & Land, H. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb06202.x · Cited by 385
Self-citationSamuels, M. L., Weber, M. J., Bishop, J. M., & McMahon, M. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.10.6241 · Cited by 347
Effects of anti-estrogens on bone in castrated and intact female rats
Jordan, V. C., Phelps, E., & Lindgren, J. U. (1987) · Breast Cancer Research and Treatment · doi:10.1007/bf01806132 · Cited by 324
Identification of two transactlvation domains in the mouse oestrogen receptor
Lees, J. A., Fawell, S. E., & Parker, M. G. (1989) · Nucleic Acids Research · doi:10.1093/nar/17.14.5477 · Cited by 295
Self-citationHarrington, E. A., Fanidi, A., & Evan, G. I. (1994) · Current Opinion in Genetics & Development · doi:10.1016/0959-437x(94)90100-7 · Cited by 265
Self-citationHope, T. J., Huang, X. J., McDonald, D., & Parslow, T. G. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.19.7787 · Cited by 226
Danielian, P. S. (1993) · Molecular Endocrinology · doi:10.1210/me.7.2.232 · Cited by 223
Self-citationBriegel, K., Lim, K. C., Plank, C., Beug, H., Engel, J. D., & Zenke, M. (1993) · Genes & Development · doi:10.1101/gad.7.6.1097 · Cited by 209
Hollenberg, S. M., Cheng, P. F., & Weintraub, H. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.17.8028 · Cited by 192
Louvion, J.-F., Havaux-Copf, B., & Picard, D. (1993) · Gene · doi:10.1016/0378-1119(93)90681-r · Cited by 185
Braselmann, S., Graninger, P., & Busslinger, M. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.5.1657 · Cited by 173
Pratt, W. B. (1990) · Molecular and Cellular Endocrinology · doi:10.1016/0303-7207(90)90198-h · Cited by 123
Chapter 16 Regulation of Protein Activities by Fusion to Steroid Binding Domains
Mattioni, T., Louvion, J.-F., & Picard, D. (1994) · Methods in cell biology · doi:10.1016/s0091-679x(08)60611-1 · Cited by 97
Superti‐Furga, G., Bergers, G., Picard, D., & Busslinger, M. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.12.5114 · Cited by 93
Burk, O., & Klempnauer, K.-H. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb04939.x · Cited by 80
Steroid-binding domains for regulating the functions of heterologous proteins in cis
Picard, D. (1993) · Trends in Cell Biology · doi:10.1016/0962-8924(93)90057-8 · Cited by 77
Boehmelt, G., Walker, A., Kabrun, N., Mellitzer, G., Beug, H., Zenke, M., & Enrietto, P. J. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05566.x · Cited by 63
Spitkovsky, D., Steiner, P., Lukáš, J., Lees, E. M., Pagano, M., Schulze, A., Joswig, S., Picard, D. J., Tommasino, M., & Eilers, M. (1994) · Journal of Virology · doi:10.1128/jvi.68.4.2206-2214.1994 · Cited by 60
Hormone‐conditional transformation by fusion proteins of c‐Abl and its transforming variants.
Jackson, P. K., Baltimore, D., & Picard, D. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05942.x · Cited by 49
Modulation of cell proliferation and gene expression by a p53-estrogen receptor hybrid protein.
Roemer, K., & Friedmann, T. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.20.9252 · Cited by 29
Schuermann, M., Hennig, G., & Müller, R. (1993) · PubMed · Cited by 27
Cited by
The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
Mani, S. A., Guo, W., Liao, M.-J., Eaton, E. N., Ayyanan, A., Zhou, A. Y., Brooks, M., Reinhard, F., Zhang, C. C., Shipitsin, M., et al. (2008) · Cell · doi:10.1016/j.cell.2008.03.027 · Cited by 8,672
The polycomb group protein EZH2 is involved in progression of prostate cancer
Varambally, S., Dhanasekaran, S. M., Zhou, M., Barrette, T. R., Kumar-Sinha, C., Sanda, M. G., Ghosh, D., Pienta, K. J., Sewalt, R. G. A. B., Otte, A. P., et al. (2002) · Nature · doi:10.1038/nature01075 · Cited by 2,717
Direct observation of individual endogenous protein complexes in situ by proximity ligation
Söderberg, O., Gullberg, M., Jarvius, M., Ridderstråle, K., Leuchowius, K.-J., Jarvius, J., Wester, K., Hydbring, P., Bahram, F., Larsson, L.-G., et al. (2006) · Nature Methods · doi:10.1038/nmeth947 · Cited by 2,419
“To verify that P-LISA specifically measures c-Myc/Max heterodimers, we used the well-known Myc-estrogen receptor (MycER) system, where c-Myc is fused to the ligand-binding domain of E”
MethodHypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours
Graeber, T. G., Osmanian, C., Jacks, T., Housman, D. E., Koch, C. J., Lowe, S. W., & Giaccia, A. J. (1996) · Nature · doi:10.1038/379088a0 · Cited by 2,300
Forkhead transcription factor FOXO3a protects quiescent cells from oxidative stress
Kops, G. J. P. L., Dansen, T. B., Polderman, P. E., Saarloos, I., Wirtz, K. W. A., Coffer, P. J., Huang, T.-T., Bos, J. L., Medema, R. H., & Burgering, B. M. T. (2002) · Nature · doi:10.1038/nature01036 · Cited by 1,580
Metadata
- Authors
- Littlewood, T. D., Hancock, D. C., Danielian, P. S., Parker, M. G., & Evan, G. I.
- Venue
- Nucleic Acids Research
- Publisher
- Oxford University Press (OUP)
- Published
- 1995-05-25
- Volume
- 23
- Issue
- 10
- Pages
- 1686-1690
- ISSN
- 0305-1048 (ISSN-L)
- 1362-4962
- OpenAlex
- W2037872087
- Cited by
- 781
- References
- 40
- FWCI
- 11.56
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.